Fenebrutinib met primary goals in two late-stage trials for the treatment of two different forms of multiple sclerosis.

That’s because the Trump administration is rewriting the disability eligibility rules, ostensibly to modernize the program, in ways that will make it even harder for aging blue-collar workers like ...

The crisis of the coming loss of SNAP benefits cannot be overstated. There are many receiving SNAP who cannot work due to disabilities.

India’s first visually impaired Rhodes Scholar, Rahul Bajaj, opens up about overcoming self-doubt, finding inclusion at ...

At the University of San Diego's Veterans Legal Clinic, law students are providing free legal services while gaining the ...

The annual application window typically opens in early November but will be “delayed indefinitely until the Trump Administration and Washington Republicans act to end the government shutdown and fund ...

The Swiss drugmaker reported that its Phase III trial known as FENhance 2 met its main goal in patients with relapsing multiple sclerosis. Fenebrutinib, taken twice daily, significantly reduced the ...

Disabled workers have told Yahoo News that their grants to stay in work have been cut off in the last year - sometimes without explanation.

Hundreds of Dallas homeowners have fallen into financial trouble after losing property tax exemptions tied to deceased ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

In his “Secrets of OPM” posts, Director Scott Kupor outlines efforts to digitize retirement processing and improve efficiency ...

As the government shutdown stretches on, military advocates are warning of long-lasting effects to National Guard troops and ...